Burning Rock Biotech Ltd (BNR)
0.77
+0.02
(+2.96%)
USD |
NASDAQ |
May 02, 10:19
Burning Rock Biotech Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0017 |
| March 31, 2022 | 0.0014 |
| December 31, 2021 | 0.0013 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0036 |
| June 30, 2021 | 0.0172 |
| March 31, 2021 | 0.0172 |
| December 31, 2020 | 0.0174 |
| September 30, 2020 | 0.0156 |
| June 30, 2020 | 0.0181 |
| March 31, 2020 | 0.0689 |
| December 31, 2019 | -0.0648 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0648
Minimum
Dec 2019
0.0689
Maximum
Mar 2020
0.0057
Average
0.0014
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0174 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 146.72M |
| Total Liabilities (Quarterly) | 38.31M |
| Shareholders Equity (Quarterly) | 108.40M |
| Current Ratio | 3.357 |